TransCode adds a unique adenovirus technology platform to its early-stage pipeline that has the potential to address a difficult to treat disease such as muscle-invasive bladder cancer. BOSTON, March ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する